Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

55
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
55
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

61
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
61
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

78
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
78
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

89
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
89
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

72
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
72
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

77
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
77

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The first prospective safety and effectiveness trial of the excimer laser assisted nonocclusive anastomosis system in coronary artery bypass grafting.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Distal Anastomotic New Entries After Type A Aortic Dissection Repair: An Underreported and Underappreciated Risk?

Annals of thoracic surgery short reports·2026
Same author

Preclinical Feasibility of the ELANA End-to-End Anastomotic Technique in a Porcine Pilot Study.

Medical devices (Auckland, N.Z.)·2026
Same author

Five-Year Quality of Life Outcome From a Randomized Controlled Trial Comparing Aortic Valve Replacement Through Upper Hemisternotomy and Full Median Sternotomy.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Minimally Invasive Mitral Valve Surgery Compared to Sternotomy in Patients Over 70 Years Old: A Retrospective Nationwide Multicentre Study in The Netherlands.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Quality of life before and after catheter ablation (pulmonary vein isolation) for atrial fibrillation: Results from the Netherlands Heart Registration.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026

Related Experiment Video

Updated: Oct 23, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

Reoperative Mitral Valve Surgery Through Port Access.

Kinsing Ko1, Thom L de Kroon2, Johannes C Kelder3

  • 1Cardiothoracic Surgery, St Antonius Hospital, Nieuwegein, The Netherlands; Cardiothoracic Surgery, Radboud UMC, Nijmegen, The Netherlands.

Seminars in Thoracic and Cardiovascular Surgery
|August 23, 2021
PubMed
Summary

Minimally invasive mitral valve surgery (MIMVS) is a safe option for reoperative procedures, showing comparable 30-day mortality and stroke rates to traditional sternotomy. This approach avoids sternotomy risks in repeat surgeries.

Keywords:
Minimally invasiveMitral valve surgeryPort accessRedoReoperativeSafety

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.1K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.9K

Related Experiment Videos

Last Updated: Oct 23, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.1K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.9K

Area of Science:

  • Cardiology
  • Thoracic Surgery
  • Minimally Invasive Surgery

Background:

  • Minimally invasive mitral valve surgery (MIMVS) is increasingly adopted for mitral valve pathology.
  • Anterolateral mini thoracotomy offers advantages in reoperative surgery by avoiding sternotomy risks.

Purpose of the Study:

  • To evaluate the safety and outcomes of reoperative MIMVS using an anterolateral mini thoracotomy approach.
  • To analyze short-term and long-term results, including complications, survival, and reoperation rates.

Main Methods:

  • Retrospective analysis of 146 patients undergoing reoperative MIMVS between 2008 and 2019.
  • Primary endpoint: 30-day major complications and mortality. Secondary endpoints: long-term survival, reoperation, and recurrent regurgitation rates.

Main Results:

  • The composite 30-day outcome was 29.5%, with 6.2% mortality and 3.4% stroke rate.
  • Long-term survival was 89.7% at 1 year, 71.6% at 5 years, and 50.9% at 8 years.
  • Reduced LV function, GFR < 60, and active endocarditis were associated with reduced long-term survival.

Conclusions:

  • Reoperative MIMVS via anterolateral mini thoracotomy demonstrates acceptable safety profiles.
  • Outcomes are comparable to repeat sternotomy, suggesting it's a viable alternative for selected patients.